Bank of America’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.9M | Sell |
|
|||||
|
2025
Q1 | $21.5M | Buy |
|
|||||
|
2024
Q4 | $3.63M | Sell |
|
|||||
|
2024
Q3 | $16.8M | Sell |
|
|||||
|
2024
Q2 | $33.7M | Sell |
|
|||||
|
2024
Q1 | $40M | Buy |
|
|||||
|
2023
Q4 | $19.1M | Sell |
|
|||||
|
2023
Q3 | $23.2M | Sell |
|
|||||
|
2023
Q2 | $24.2M | Buy |
|
|||||
|
2023
Q1 | $2.14M | Sell |
|
|||||
|
2022
Q4 | $3.64M | Buy |
|
|||||
|
2022
Q3 | $2.13M | Buy |
|
|||||
|
2022
Q2 | $1.67M | Buy |
|
|||||
|
2022
Q1 | $1.85M | Buy |
|
|||||
|
2021
Q4 | $1.44M | Sell |
|
|||||
|
2021
Q3 | $2.4M | Sell |
|
|||||
|
2021
Q2 | $1.99M | Buy |
|
|||||
|
2021
Q1 | $1.41M | Buy |
|
|||||
|
2020
Q4 | $1M | Buy |
|
|||||
|
2020
Q3 | $698K | Buy |
|
|||||
|
2020
Q2 | $544K | Sell |
|
|||||
|
2020
Q1 | $1.92M | Buy |
|
|||||
|
2019
Q4 | $1.61M | Sell |
|
|||||
|
2019
Q3 | $1.49M | Sell |
|
|||||
|
2019
Q2 | $2.55M | Buy |
|
|||||
|
2019
Q1 | $2.39M | Buy |
|
|||||
|
2018
Q4 | $908K | Sell |
|
|||||
|
2018
Q3 | $3.83M | Buy |
|
|||||
|
2018
Q2 | $2.12M | Buy |
|
|||||
|
2018
Q1 | $295K | Sell |
|
|||||
|
2017
Q4 | $409K | Buy |
|
|||||
|
2017
Q3 | $160K | Sell |
|
|||||
|
2017
Q2 | $134K | Sell |
|
|||||
|
2017
Q1 | $150K | Buy |
|
|||||
|
2016
Q4 | $88K | Buy |
|
|||||
|
2016
Q3 | $65K | Sell |
|
|||||
|
2016
Q2 | $680K | Buy |
|
|||||
|
2016
Q1 | $414K | Buy |
|
|||||
|
2015
Q4 | $382K | Buy |
|
|||||
|
2015
Q3 | $337K | Sell |
|
|||||
|
2015
Q2 | $341K | Buy |
|
|||||
|
2015
Q1 | $293K | Buy |
|